---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-075721"
form_type: "8-K"
ticker: "VREOF"
cik: "0001771706"
company_name: "Vireo Growth Inc."
filed_at: "2026-06-18T20:05:40+00:00"
generated_at: "2026-06-18T20:13:50.889012+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vireo Growth to acquire C21 Investments in all-stock deal; exchange ratio 0.023052

## Summary
- Each C21 share exchanged for 0.023052 Vireo subordinate voting shares; C21 shareholders to vote in Q3 2026.
- Acquisition adds ~15 Nevada dispensaries and 158,000 sq ft of cultivation/manufacturing capacity.
- Termination fee of $3M payable by C21 in certain circumstances; outside date May 31, 2027.
- Transaction requires C21 shareholder approval (2/3 majority), court orders, and regulatory approvals.
- C21 board and special committee unanimously recommend deal; Needham & Co. provided fairness opinion.

## SEC filing metadata
- accession: 0001104659-26-075721
- form_type: 8-K
- ticker: VREOF
- cik: 0001771706
- company_name: Vireo Growth Inc.
- filed_at: 2026-06-18T20:05:40+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771706/000110465926075721/0001104659-26-075721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771706/000110465926075721/tm2617497d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-075721
- JSON: https://secwatch.observer/filing/0001104659-26-075721.json
- Plain text: https://secwatch.observer/filing/0001104659-26-075721.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.